Federal Supply Schedule V797D70105

Award Date 3/16/17
Last Date to Order 3/15/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed

This federal contract indefinite delivery vehicle (IDV) is a General Services Administration (GSA) Federal Supply Schedule contract awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at up to $260,000,000.01, provides the VA and other federal agencies with a streamlined vehicle to acquire critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services from Roche over a 10-year period ending in 2027. This includes instruments such as the COBAS TaqMan, AmpliPrep, and 4800/6800 analyzers, as well as testing kits, reagents, and consumables for immunochemistry, hematology, molecular diagnostics, microbiology, and other laboratory capabilities. The contract does not have any set-aside designations.

Through the IDV, the VA and other federal agencies have placed multiple firm fixed-price delivery orders and established Blanket Purchase Agreements (BPAs) with Roche to acquire essential medical equipment and consumables on an as-needed basis. These task orders and BPAs, valued from hundreds of thousands to over $14 million, support healthcare services for veterans, active duty military, and other patient populations at VA medical centers, military treatment facilities, NIH research centers, and Indian Health Service locations across the country. By leveraging Roche's existing GSA Schedule contract, these contracting mechanisms streamline federal procurement of the critical laboratory instruments, reagents, and testing services required to diagnose and treat viral infections, cancer, and other medical conditions.

Generated 1/23/25, 9:05 AM